Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.190 USD  +0.270 (+6.89%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about BioTime, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Top Narrow Based Indexes For November 19, 2012
November 19, 2012
By 10:12 am, the Dow Jones Industrial Average was up 144.18 points, or 1.15%, to 12,732.49, while the broader Standard & Poor's 500 index had gained 19.17 points, or 1.41%. The NASDAQ composite index... Read More
category IL0010823792 , Benzinga , Movers , and 9 more.
from Latest Articles from Benzinga.com
StreetInsider.com Pre-Open Movers 11/16: (PENN) (SHF) (OMX) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
November 16, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7886279 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com After-Hours Movers 11/15: (SHF) (ARUN) (GPS) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
November 15, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7885336 for the full story. Read More
from StreetInsider.com News Articles
BioTime and BioTime Acquisition Corporation Announce Combined $10 Million Financing
November 15, 2012
from Business Wire News Releases
Geron (GERN) Receives non-Binding LoI with BioTime (BTX)
November 15, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7884659 for the full story. Read More
from StreetInsider.com News Articles
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
November 15, 2012
from Business Wire News Releases
BioTime and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal
November 14, 2012
from Business Wire News Releases
Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc.
November 12, 2012
BioTime to provide $3.5 million in stock to Cell Cure to fund clinical development of OpRegen® for the treatment of age-related macular degeneration Read More
from PR Newswire
BioTime Announces Third Quarter 2012 Financial Results and Recent Corporate Accomplishments
November 09, 2012
from Business Wire News Releases
BioTime and Subsidiary Cell Cure Neurosciences Ltd. Announce Financing
November 07, 2012
from Business Wire News Releases
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
November 01, 2012
from Business Wire News Releases
BioTime’s Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards - A Database of Human Diseases
October 23, 2012
from Business Wire News Releases
LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development
October 19, 2012
from Business Wire News Releases
BioTime, Inc. Issues Open Letter to Shareholders of Geron Corporation
October 18, 2012
from Business Wire News Releases
4 Biotechnology Stocks to Sell Now
October 17, 2012
 Read More
category Stocks to Sell , AMEX:YMI , NASDAQ:IMGN , and 2 more.
from InvestorPlace - Latest Headlines
BioTime Forms BioTime Acquisition Corporation
September 28, 2012
from Business Wire News Releases
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012
September 19, 2012
from Business Wire News Releases
Biotonix annonce les résultats du deuxième trimestre de 2012
August 28, 2012
from Marketwired
Biotonix Announces Second Quarter 2012 Results
August 28, 2012
from Marketwired
BioTime (BTX) Expands Licensing on HyStem-Ccvered Products
August 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7686088 for the full story. Read More
from StreetInsider.com News Articles
BioTime Obtains Expanded License to HyStem® Technology
August 27, 2012
from Business Wire News Releases
BioTime (BTX) Publishes Encouraging Data for COL10A1 on Various Types of Human Cancers
August 16, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7666717 for the full story. Read More
from StreetInsider.com News Articles
BioTime and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers
August 16, 2012
from Business Wire News Releases
BioTime Announces Second Quarter 2012 Financial Results and Recent Corporate Accomplishments
August 09, 2012
from Business Wire News Releases
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant From Israel’s Office of the Chief Scientist
August 01, 2012
from Business Wire News Releases
BioTime (BTX) Files 868K Common Shelf for Shareholders
August 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7620376 for the full story. Read More
from StreetInsider.com News Articles
BioTime Subsidiary LifeMap Sciences, Inc. Announces Financing of Up to $3 Million from Share Exchange Agreement
July 26, 2012
from Business Wire News Releases
BioTime (BTX) Enters Exclusive Sublicense with Jade Therapeutics for HyStem Hydrogels
July 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7583840 for the full story. Read More
from StreetInsider.com News Articles
BioTime Signs Agreements with Jade Therapeutics for Ophthalmological Drug Delivery Applications of HyStem® Technology
July 17, 2012
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at the 2012 Agora Financial Investment Symposium
July 16, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here